Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 4:18 pm Sale |
2024-09-30 | 13G | Invivyd, Inc. IVVD |
GV 2019 L.P. | 0 0.000% |
-5,680,785 (Position Closed) |
Filing History |
| 2024-02-29 4:15 pm Purchase |
2024-02-20 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 15,062,498 12.200% |
3,200,000 (+26.98%) |
Filing History |
| 2024-02-09 4:09 pm Sale |
2023-12-31 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 11,862,498 12.200% |
-1,422,190 (-10.71%) |
Filing History |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | Prime Medicine, Inc. PRME |
GV 2019 L.P. | 13,284,688 13.700% |
13,284,688 (New Position) |
Filing History |
| 2022-02-14 12:36 pm Purchase |
2021-12-31 | 13G | EQRx, Inc. EQRX |
GV 2019 L.P. | 47,252,687 9.690% |
47,252,687 (New Position) |
Filing History |
| 2022-02-14 12:30 pm Purchase |
2021-12-31 | 13G | Invivyd, Inc. IVVD |
GV 2019 L.P. | 5,680,785 5.110% |
5,680,785 (New Position) |
Filing History |